Earnings History Data for Restorgenex Corp. (DFFN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Restorgenex Corp.

Diffusion Pharmaceuticals Inc. is a biotechnology company. Its product pipeline includes Trans Sodium Crocetinate, Glioblastoma Program, Pancreatic Cancer Program and Brain Metastases Program. The Company is focused on cancer treatments, such as radiation therapy and chemotherapy in treatment-resistant solid tumors. Diffusion Pharmaceuticals Inc., formerly known as RestorGenex Corporation, is based in Charlottesville, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-08-2021 PM DFFN Restorgenex Corp. 56.00 -0.04 -0.05 0.00 Diffusion Pharmaceuticals reports Q2 results
[8/11/2021 7:47 AM]
0.5374 -0.03 
(-5.57%)
0.59 0.02 
(2.93%)
0.51 - 1.85 2,249,661 1,220,000 85,826
10-05-2021 PM DFFN Diffusion Pharmaceuticals Inc. 69.35 -0.06 -0.05 -0.07 Diffusion Pharmaceuticals EPS misses by $0.02
[5/10/2021 7:54 AM]
0.7693 0.09 
(12.75%)
0.71 0.03 
(4.00%)
0.61 - 1.85 3,554,572 1,150,000 499,639